PubRank

F S Nielsen

Author PubWeight™ 30.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995 1.57
2 Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes 1995 1.51
3 The crystal structure of Lactococcus lactis dihydroorotate dehydrogenase A complexed with the enzyme reaction product throws light on its enzymatic function. Protein Sci 1998 1.24
4 Short stature and diabetic nephropathy. BMJ 1995 1.24
5 Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993 1.23
6 The crystal structure of the flavin containing enzyme dihydroorotate dehydrogenase A from Lactococcus lactis. Structure 1997 1.22
7 Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995 1.20
8 Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study. Diabetes Care 1999 1.01
9 Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients. Diabetes 1998 0.94
10 Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int 1995 0.94
11 Low birth weight. A risk factor for development of diabetic nephropathy? Diabetes 1995 0.91
12 The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1993 0.91
13 Glomerular hyperfiltration in microalbuminuric NIDDM patients. Diabetologia 1996 0.91
14 Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care 1994 0.89
15 Fish oil in diabetic nephropathy. Diabetes Care 1996 0.89
16 Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy. Diabetes 1996 0.84
17 Ascorbic acid uptake to isolated nerve terminals and secretory granules from ox neurohypophyses. Acta Physiol Scand 1985 0.83
18 Left ventricular hypertrophy in normoalbuminuric type 2 diabetic patients not taking antihypertensive treatment. QJM 2005 0.83
19 Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2000 0.82
20 Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy. Diabetologia 1996 0.82
21 Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1994 0.81
22 Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy. Nephrol Dial Transplant 1996 0.80
23 Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy. Diabet Med 1999 0.80
24 Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy. Kidney Int 1996 0.80
25 Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patient with and without diabetic nephropathy. J Intern Med Suppl 1994 0.79
26 Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy. Scand J Clin Lab Invest 1992 0.79
27 Biochemical characterization of the heteromeric Bacillus subtilis dihydroorotate dehydrogenase and its isolated subunits. Arch Biochem Biophys 1999 0.79
28 Uptake of dehydroascorbic acid and ascorbic acid to isolated nerve terminals and secretory granules from ox neurohypophyses. Acta Physiol Scand 1986 0.78
29 Crystallization and preliminary X-ray diffraction analysis of the heterotetrameric dihydroorotate dehydrogenase B of Lactococcus lactis, a flavoprotein enzyme system consisting of two PyrDB subunits and two iron-sulfur cluster containing PyrK subunits. Acta Crystallogr D Biol Crystallogr 1997 0.77
30 Characteristics of ascorbic acid uptake by isolated ox neurohypophyseal nerve terminals and the influence of glucocorticoid and tri-iodothyronine on uptake. Acta Physiol Scand 1991 0.77
31 Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment. Diabetes 1997 0.76
32 Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM. Diabetes 1997 0.76
33 Pharmacokinetics following continuous subcutaneous insulin infusion of insulin aspart with or without initial subcutaneous bolus. Diabetes Obes Metab 2010 0.76
34 Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy. Diabetes Care 1996 0.75
35 Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy. Diabetes Care 1999 0.75
36 [Low birth weight--increased risk of diabetic nephropathies?]. Ugeskr Laeger 1996 0.75
37 Preventing diabetic nephropathy: an audit. Scand J Clin Lab Invest 2001 0.75
38 Glucocorticoids and tri-iodothyronine inhibit uptake of ascorbic acid to isolated nerve terminals from ox neurohypophyses. Acta Physiol Scand 1986 0.75
39 [Albuminuria and glycemic control. The significance for mortality in non-insulin-dependent diabetes mellitus]. Ugeskr Laeger 1996 0.75
40 Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy. Kidney Int Suppl 1997 0.75